Mycophenolic acid analogs with a modified metabolic profile

Liqiang Chen, Daniel J. Wilson, Nicholas P. Labello, Hiremagalur N. Jayaram, Krzysztof W. Pankiewicz

Research output: Contribution to journalArticle

11 Scopus citations

Abstract

Mycophenolic acid (MPA), a clinically used immunosuppressant, is extensively metabolized into an inactive C7-glucuronide and removed from circulation. To circumvent the metabolic liability imposed by the C7-hydroxyl group, we have designed a series of hybrid MPA analogs based on the pharmacophores present in MPA and new generations of inosine monophosphate dehydrogenase (IMPDH) inhibitors. The synthesis of MPA analogs has been accomplished by an allylic substitution of a common lactone. Biological evaluations of these analogs and a preliminary structure-activity relationship (SAR) are presented.

Original languageEnglish (US)
Pages (from-to)9340-9345
Number of pages6
JournalBioorganic and Medicinal Chemistry
Volume16
Issue number20
DOIs
StatePublished - Oct 15 2008

Keywords

  • Allylic substitution
  • Inosine monophosphate dehydrogenase
  • Mycophenolic acid

ASJC Scopus subject areas

  • Pharmaceutical Science
  • Drug Discovery
  • Organic Chemistry
  • Molecular Medicine
  • Molecular Biology
  • Clinical Biochemistry
  • Biochemistry

Fingerprint Dive into the research topics of 'Mycophenolic acid analogs with a modified metabolic profile'. Together they form a unique fingerprint.

  • Cite this

    Chen, L., Wilson, D. J., Labello, N. P., Jayaram, H. N., & Pankiewicz, K. W. (2008). Mycophenolic acid analogs with a modified metabolic profile. Bioorganic and Medicinal Chemistry, 16(20), 9340-9345. https://doi.org/10.1016/j.bmc.2008.08.062